Global and United States Brain Tumor Therapeutics Market Report & Forecast 2024-2031

Report ID: 1861710 | Published Date: Oct 2024 | No. of Page: 101 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Brain Tumor Therapeutics Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Brain Tumor Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Brain Tumor Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Brain Tumor Therapeutics Market Size for the Year 2017-2028
    1.3 Brain Tumor Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Brain Tumor Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Brain Tumor Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Brain Tumor Therapeutics Market Dynamics
        1.4.1 Brain Tumor Therapeutics Industry Trends
        1.4.2 Brain Tumor Therapeutics Market Drivers
        1.4.3 Brain Tumor Therapeutics Market Challenges
        1.4.4 Brain Tumor Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Brain Tumor Therapeutics by Type
    2.1 Brain Tumor Therapeutics Market Segment by Type
        2.1.1 Surgery
        2.1.2 Radiation Therapy
        2.1.3 Targeted Therapy
        2.1.4 Chemotherapy
        2.1.5 Immunotherapy
    2.2 Global Brain Tumor Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Brain Tumor Therapeutics Market Size by Type (2017-2028)
    2.4 United States Brain Tumor Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Brain Tumor Therapeutics Market Size by Type (2017-2028)
3 Brain Tumor Therapeutics by Application
    3.1 Brain Tumor Therapeutics Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Oncology Treatment Centers
        3.1.3 Others
    3.2 Global Brain Tumor Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Brain Tumor Therapeutics Market Size by Application (2017-2028)
    3.4 United States Brain Tumor Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Brain Tumor Therapeutics Market Size by Application (2017-2028)
4 Global Brain Tumor Therapeutics Competitor Landscape by Company
    4.1 Global Brain Tumor Therapeutics Market Size by Company
        4.1.1 Top Global Brain Tumor Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Brain Tumor Therapeutics Revenue by Player (2017-2022)
    4.2 Global Brain Tumor Therapeutics Concentration Ratio (CR)
        4.2.1 Brain Tumor Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Brain Tumor Therapeutics in 2021
        4.2.3 Global Brain Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Brain Tumor Therapeutics Headquarters, Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Brain Tumor Therapeutics Headquarters and Area Served
        4.3.2 Global Brain Tumor Therapeutics Companies Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Brain Tumor Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Brain Tumor Therapeutics Market Size by Company
        4.5.1 Top Brain Tumor Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Brain Tumor Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Brain Tumor Therapeutics Market Size by Region
    5.1 Global Brain Tumor Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Brain Tumor Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Brain Tumor Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Brain Tumor Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Brain Tumor Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Brain Tumor Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Brain Tumor Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Brain Tumor Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Brain Tumor Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Brain Tumor Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Brain Tumor Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Brain Tumor Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Brain Tumor Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Brain Tumor Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Details
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Brain Tumor Therapeutics Introduction
        7.1.4 Pfizer Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.1.5 Pfizer Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Brain Tumor Therapeutics Introduction
        7.2.4 Novartis Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.2.5 Novartis Recent Development
    7.3 Roche
        7.3.1 Roche Company Details
        7.3.2 Roche Business Overview
        7.3.3 Roche Brain Tumor Therapeutics Introduction
        7.3.4 Roche Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.3.5 Roche Recent Development
    7.4 Merck
        7.4.1 Merck Company Details
        7.4.2 Merck Business Overview
        7.4.3 Merck Brain Tumor Therapeutics Introduction
        7.4.4 Merck Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.4.5 Merck Recent Development
    7.5 AstraZeneca
        7.5.1 AstraZeneca Company Details
        7.5.2 AstraZeneca Business Overview
        7.5.3 AstraZeneca Brain Tumor Therapeutics Introduction
        7.5.4 AstraZeneca Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.5.5 AstraZeneca Recent Development
    7.6 GE Healthcare
        7.6.1 GE Healthcare Company Details
        7.6.2 GE Healthcare Business Overview
        7.6.3 GE Healthcare Brain Tumor Therapeutics Introduction
        7.6.4 GE Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.6.5 GE Healthcare Recent Development
    7.7 Hitachi Medical
        7.7.1 Hitachi Medical Company Details
        7.7.2 Hitachi Medical Business Overview
        7.7.3 Hitachi Medical Brain Tumor Therapeutics Introduction
        7.7.4 Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.7.5 Hitachi Medical Recent Development
    7.8 Philips Healthcare
        7.8.1 Philips Healthcare Company Details
        7.8.2 Philips Healthcare Business Overview
        7.8.3 Philips Healthcare Brain Tumor Therapeutics Introduction
        7.8.4 Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.8.5 Philips Healthcare Recent Development
    7.9 Novocure
        7.9.1 Novocure Company Details
        7.9.2 Novocure Business Overview
        7.9.3 Novocure Brain Tumor Therapeutics Introduction
        7.9.4 Novocure Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.9.5 Novocure Recent Development
    7.10 DelMar Pharmaceuticals
        7.10.1 DelMar Pharmaceuticals Company Details
        7.10.2 DelMar Pharmaceuticals Business Overview
        7.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Introduction
        7.10.4 DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2017-2022)
        7.10.5 DelMar Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Brain Tumor Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Brain Tumor Therapeutics Market Trends
    Table 3. Brain Tumor Therapeutics Market Drivers
    Table 4. Brain Tumor Therapeutics Market Challenges
    Table 5. Brain Tumor Therapeutics Market Restraints
    Table 6. Global Brain Tumor Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Brain Tumor Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Brain Tumor Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Brain Tumor Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Brain Tumor Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Brain Tumor Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Brain Tumor Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Brain Tumor Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Brain Tumor Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Therapeutics as of 2021)
    Table 15. Top Players of Brain Tumor Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Brain Tumor Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Brain Tumor Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Brain Tumor Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Brain Tumor Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Brain Tumor Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Brain Tumor Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Brain Tumor Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Brain Tumor Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Brain Tumor Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Brain Tumor Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Brain Tumor Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Brain Tumor Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Brain Tumor Therapeutics Product
    Table 33. Pfizer Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Brain Tumor Therapeutics Product
    Table 38. Novartis Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Roche Company Details
    Table 41. Roche Business Overview
    Table 42. Roche Brain Tumor Therapeutics Product
    Table 43. Roche Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Roche Recent Development
    Table 45. Merck Company Details
    Table 46. Merck Business Overview
    Table 47. Merck Brain Tumor Therapeutics Product
    Table 48. Merck Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. AstraZeneca Company Details
    Table 51. AstraZeneca Business Overview
    Table 52. AstraZeneca Brain Tumor Therapeutics Product
    Table 53. AstraZeneca Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. AstraZeneca Recent Development
    Table 55. GE Healthcare Company Details
    Table 56. GE Healthcare Business Overview
    Table 57. GE Healthcare Brain Tumor Therapeutics Product
    Table 58. GE Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. GE Healthcare Recent Development
    Table 60. Hitachi Medical Company Details
    Table 61. Hitachi Medical Business Overview
    Table 62. Hitachi Medical Brain Tumor Therapeutics Product
    Table 63. Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Hitachi Medical Recent Development
    Table 65. Philips Healthcare Company Details
    Table 66. Philips Healthcare Business Overview
    Table 67. Philips Healthcare Brain Tumor Therapeutics Product
    Table 68. Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Philips Healthcare Recent Development
    Table 70. Novocure Company Details
    Table 71. Novocure Business Overview
    Table 72. Novocure Brain Tumor Therapeutics Product
    Table 73. Novocure Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Novocure Recent Development
    Table 75. DelMar Pharmaceuticals Company Details
    Table 76. DelMar Pharmaceuticals Business Overview
    Table 77. DelMar Pharmaceuticals Brain Tumor Therapeutics Product
    Table 78. DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. DelMar Pharmaceuticals Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Brain Tumor Therapeutics Product Picture
    Figure 2. Global Brain Tumor Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Brain Tumor Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Brain Tumor Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Brain Tumor Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Brain Tumor Therapeutics Market Share in Global 2017-2028
    Figure 7. Brain Tumor Therapeutics Report Years Considered
    Figure 8. Product Picture of Surgery
    Figure 9. Product Picture of Radiation Therapy
    Figure 10. Product Picture of Targeted Therapy
    Figure 11. Product Picture of Chemotherapy
    Figure 12. Product Picture of Immunotherapy
    Figure 13. Global Brain Tumor Therapeutics Market Share by Type in 2022 & 2028
    Figure 14. Global Brain Tumor Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Brain Tumor Therapeutics Market Share by Type (2017-2028)
    Figure 16. United States Brain Tumor Therapeutics Market Share by Type in 2022 & 2028
    Figure 17. United States Brain Tumor Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Brain Tumor Therapeutics Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Oncology Treatment Centers
    Figure 21. Product Picture of Others
    Figure 22. Global Brain Tumor Therapeutics Market Share by Application in 2022 & 2028
    Figure 23. Global Brain Tumor Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Brain Tumor Therapeutics Market Share by Application (2017-2028)
    Figure 25. United States Brain Tumor Therapeutics Market Share by Application in 2022 & 2028
    Figure 26. United States Brain Tumor Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Brain Tumor Therapeutics Market Share by Application (2017-2028)
    Figure 28. North America Brain Tumor Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Brain Tumor Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Brain Tumor Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Brain Tumor Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Brain Tumor Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Brain Tumor Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 60. AstraZeneca Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 61. GE Healthcare Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 62. Hitachi Medical Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 63. Philips Healthcare Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 64. Novocure Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 65. DelMar Pharmaceuticals Revenue Growth Rate in Brain Tumor Therapeutics Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals
Frequently Asked Questions
Brain Tumor Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Brain Tumor Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Brain Tumor Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Braze Alloys

Braze Alloys market is segmented by region (country), players, by Type and by Application. Player ... Read More

Linings

Linings market is segmented by region (country), players, by Type and by Application. Players, st ... Read More